ISRG vs REPL · P/E 80, rev $10.06B vs $825.7M cap
Intuitive Surgical Inc (ISRG) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Intuitive Surgical Inc (ISRG) is a medical instruments & supplies company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported ISRG revenue for 2025-12-31 was $10.06B. Net income was $2.86B. Revenue was up 20.5% from 2024-12-31 to 2025-12-31. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
REPL does not have a complete income-statement cache yet.
ISRG currently screens at market cap $195.15B and trailing P/E 80.0. REPL currently screens at market cap $825.7M.
Not investment advice. Open the ISRG and REPL stock pages for the full models.
Not investment advice.